B. Braun is a medical technology and healthcare solutions company founded in 1839 as a pharmacy in Melsungen, Germany. The company has remained family-owned across six generations and now employs more than 64,000 people worldwide, with operations spanning every continent and annual sales of approximately €9.4 billion.
The company operates across several core areas: infusion therapy and single-use infusion devices, pharmaceutical production, clinical nutrition, extracorporeal blood treatment including dialysis equipment, and surgical instruments and technologies through its Aesculap division. B. Braun developed the Braunüle, a revolutionary single-use plastic infusion device introduced in the 1950s that improved patient safety and comfort, and launched Lipofundin, a clinical nutrition product, in 1962.
B. Braun positions itself as providing integrated healthcare solutions aimed at protecting and improving people's health. The company's long operational history, continuous technological innovation, and diversified portfolio across medical devices, pharmaceuticals, and clinical care reflect its emphasis on both pioneering advancement and sustained global presence in healthcare.